Perventricular device closure of ventricular septal defects: results in patients less than 1 year of age

Abstract

Perventricular device closure of ventricular septal defects showed safety and high efficiency in patients less than 1 year of age, compared with conventional surgical repair with cardiopulmonary bypass, and provided a short period of rehabilitation and excellent cosmetic result.

Effects of transthoracic device closure on ventricular septal defects and reasons for conversion to open-heart surgery: A meta-analysis

“…Among all the selected articles, 146 trials were conducted primarily in China 4–6,12,25–34,36–53,55–59,61,63,65–160,162,167,168,171–175,180,185,186 , 3 articles were conducted in other Asian countries (one each in India, South Korea and Turkey) 166,169,184 , 10 studies were conducted in the United States 11,62,64,163,170,176,178,179,181,182 , 5 studies were performed in European countries (one each in Austria, France, Germany, Poland, Russian Federation) 35,54,161,165,183 , 2 articles were conducted in South American countries (1 Brazil and 1 Chile) 164,177 , and 1 case-control study was performed in Australia 60 . A total of 108 articles were written in Chinese 5,12,26–29,31,32,36–43,46,70–132,134–159,174,175 , whereas 58 articles were written in English 4,6,11,25,30,33–35,44,45,47–69,133,160–163,165–173,176–186 , and the remaining article was written in Portuguese 164 .…”

“…Two case-control studies did not mention the comparability of cases and controls, and one only controlled for age. Of the 129 identified case series, 56 studies (43.42%) were considered to be of acceptable quality according to the 18-item, validated quality appraisal tool 47–50,52,54,56,58,60,61,64,66,68–70,72–74,76,81,89,92,95,98,103–105,113,115,117,125,128,129,131,135,136,138,140,141,145,146,149,152,153,155,156,158,160,162,164–166,168,171–173 (Supplemental Table 4). Four series did not clearly elucidate the study objective in the abstract, introduction or methods section; five did not account for the characteristics of the included participants; 121 case series collected cases at a single centre; 85 did not apply the criteria for inclusion; two recruited participants inconsecutively; four did not clearly describe the primary or additional interventions; 20 did not clearly defined the outcome measures in the introduction or methods section; 116 did not use appropriate statistical tests to assess the relevant outcome; 17 did not report the length of follow-up; 59 did not report the loss of follow-up; 53 did not estimate the random variability of the outcomes; 1 did not report the adverse events; most of the series (n = 128) did not report the source of support for the study.…”

Peratrial Device Closure of Atrial Septal Defect Under Transesophageal Echocardiographic Guidance without Fluoroscopy Compared to Conventional On-Pump Surgical Closure

“…TEE is developed on the basis of conventional echocardiography [3,6] . The probe is placed in the esophagus, which is close to the posterior wall of the left atrium without interference of the chest wall and lung gas.…”

“…Ventricular septal defect (VSD) and atrial septal defect (ASD) are two kinds of CHD with about 30% of the total number of CHD in China [3] . Currently, the main treatment methods for CHD include cardiopulmonary bypass (CPB) surgery, percutaneous catheter interventional occlusion and recently developed transesophageal echocardiography (TEE) guided percutaneously with minimally invasive incision closure.…”

Echocardiography-guided percutaneous closure of perimembranous ventricular septal defects without arterial access and fluoroscopy

“…In an effort to reduce injury related to fluoroscopy and angiography, another alternative technique is direct ventricular puncture using to close the VSD with a beating heart using an occluder recently came into practice. This method is widely used in China [4][5][6][7][8] and other countries [9][10][11][12]. However, there are still some disadvantages with this technique, including surgical trauma, incision, and scarring.…”